...
首页> 外文期刊>Annals of nuclear medicine >Prediction of lack of response to neoadjuvant chemotherapy in rare breast tumour histology with Tc-99m sestamibi scintimammography.
【24h】

Prediction of lack of response to neoadjuvant chemotherapy in rare breast tumour histology with Tc-99m sestamibi scintimammography.

机译:Tc-99m西司他比闪烁摄影术可预测在罕见的乳腺肿瘤组织学中对新辅助化疗缺乏反应。

获取原文
获取原文并翻译 | 示例

摘要

The authors report a case of a 47-year-old female with a malignant lump in the right breast and ipsilateral axillary nodal involvement. She was pathologically misinterpreted as a case of ductal cell carcinoma with papillary component on fine needle aspiration cytology (FNAC) pre-operatively. On lines of the FNAC report, the patient underwent scintimammography (SMM) for prediction of treatment response based on washout pattern. The SMM revealed rapid washout of radiotracer predictive of poor responder. Despite unfavourable result seen with SMM, the patient received 4 cycles of neo-adjuvant chemotherapy (NACT). However, there was no clinical response after chemotherapy. The post-surgical histopathology revealed the actual histology to be pleomorphic liposarcoma. This case highlights that SMM has the ability to predict non-responsiveness of unusual tumour histology to standard NACT.
机译:作者报告了一例47岁的女性,右乳房恶性肿块,患侧腋窝淋巴结受累。术前,她被病理学误解为导管导管癌,并在细针穿刺细胞学检查(FNAC)上有乳头状成分。根据FNAC报告的内容,患者接受了X线断层扫描(SMM),以根据洗脱模式预测治疗反应。 SMM揭示了放射性示踪剂的快速清除,预示着不良反应。尽管SMM观察到不良结果,但患者仍接受了4个周期的新辅助化疗(NACT)。但是,化疗后没有临床反应。手术后的组织病理学揭示了实际的组织学是多形性脂肪肉瘤。这种情况表明,SMM具有预测异常肿瘤组织学对标准NACT的无反应性的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号